Medical Products of Human Origin, UDI and ICCBBA: Supply Chain’s Role Podcast

By AHRMM

Some Human Cellular Tissue Products (HCTP) are considered “devices” and will require their assigned Unique Device Identifiers (UDI) to be tracked within the patient’s Electronic Health Record (EHR) and shared across the healthcare spectrum. Supply chain should be having interdepartmental conversations to determine how they will handle these types of products and their UDIs.

Related Resources

Advisory
Relative Humidity in the OR Environment
Background:
Case Studies
Leading Practice: Reduction or Elimination of CAUTI - Nexera, Inc.
AHRMM is offering a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
Case Studies
Leading Practice: Reduction or Elimination of HAPU - Nexera
The following leading practice describes methods used to reduce Hospital Acquired Pressure Ulcers (HAPU).
Advisory
Guidance on Humidity Levels in the Operating Room
New Guidance on Humidity Levels in the Operating Room
Letter/Comment
AHRMM Comment Letter to FDA Regarding the Draft Guidance for Industry on the Global Unique Device Identification Database (GUDID)
On November 21, 2013, AHRMM submitted electronically
Supply Chain Strategies & Solutions Article
The Future for Effective Healthcare Supply Change Is Balancing Cost, Quality, and Outcomes
Supply chain must play an integral role in the care delivery process through cross-departmental partnerships that support evidence-based valu